Table 1.
Treatment type | Bee spore load1 | Bee survival1 | Hive spore load2 | Other effects | References |
---|---|---|---|---|---|
SMALL MOLECULES | |||||
Metronidazole (in vitro only)** | N/A | N/A | N/A | ↓spore viability | (44) |
Tinidazole (in vitro only)** | N/A | N/A | N/A | ↓spore viability | (44) |
Porphyrin: PP(Asp)2 | ↓ | ↑ | N/A | ↓spore viability | (45) |
Porphyrin: TMePyP | ↓ | N/A | N/A | ↓spore viability | (45) |
Fumagillin analogsa* | ↓ | † | N/A | N/A | (46) |
Fumagillol* | ↓ | † | N/A | N/A | (46) |
Semisynthetic aspirin* | ↓ | † | N/A | N/A | (46) |
Enilconazole* | ↓ | † | N/A | N/A | (46) |
Piperonyl analog* | ↓ | † | N/A | N/A | (46) |
Thymol* | ↓ | † | N/A | N/A | (46) |
Formic acid (fumigation) | N/A | N/A | ↓ | N/A | (47) |
Oxalic acid | ↓ | N/A | N/A | N/A | (48) |
Oxalic acid (topical field trial) | N/A | N/A | ↓ | ↑colony survival | (48) |
Thymol | ↓ | ↑ | N/A | N/A | (49) |
Resveratrol | No Effect | ↑ | N/A | N/A | (49) |
Thymol | ↓ | No Effect | N/A | N/A | (50) |
Resveratrol | ↓ | ↑ | N/A | N/A | (50) |
RNA INTERFERENCE | |||||
ADP/ATP transporter RNAi | ↓ | N/A | N/A | ↑response to sucrose | (51) |
ptp3 RNAi | ↓ | ↑ | N/A | ↑immune expression | (52) |
nkd RNAi | ↓ | ↑ | N/A | ↑immune expression | (53) |
EXTRACTS AND SUPPLEMENTS | |||||
Polysaccharide extracts* | ↓ | ↑ | N/A | N/A | (54) |
Pentadecapeptide BPC 157 | N/A | N/A | ↓ | ↓bee midgut lesions; ↑colony strength | (55) |
EtOH L. nobilis Extract | ↓ | No Effect | N/A | N/A | (56, 57) |
C. alba EO extract** | ↓ | ↑ | N/A | N/A | (58) |
Compounds detected in C. alba EO extract+* | ↓ | ↑ | N/A | N/A | (58) |
MeOH A. chilensis extract | ↓ | No Effect | N/A | N/A | (59) |
MeOH U. molinae extract | ↓ | ↑ | N/A | N/A | (59) |
MeOH G. avellana extract | ↓ | No Effect | N/A | N/A | (59) |
MeOH propolis extract | ↓ | ↑ | N/A | N/A | (59) |
EtOH propolis extractb | ↓ | ↑ | N/A | N/A | (60) |
EtOH propolis extractc | ↓ | ↑ | N/A | N/A | (61) |
BEEWELL AminoPlus | ↓ | No Effect | N/A | ↑immune expression | (62) |
Nozevitd | N/A | N/A | ↓ | ↑colony strength | (63) |
HiveAlive | N/A | N/A | ↓ | ↑colony strength | (64) |
MICROBIAL SUPPLEMENTS | |||||
Bacterial surfactin | ↓ | ↑ | N/A | ↓spore viability | (65) |
L. johnsonii metabolites | N/A | N/A | ↓ | ↑fat bodies per bee; ↑colony strength | (66) |
Bifidobacteria | ↓ | N/A | N/A | N/A | (67) |
Lactobacilli | ↓ | N/A | N/A | N/A | (67) |
P. apium | No Effect | ↑ | N/A | N/A | (68) |
Bacillus sp. | No Effect | ↑ | N/A | N/A | (68) |
Bactocell | No Effect | ↑ | N/A | N/A | (68) |
Levucell SB | No Effect | ↑ | N/A | N/A | (68) |
Treatments not delivered orally are labeled as such. An increase is marked by “↑” and a decrease by “↓”. Metrics that were not measured are labeled non-applicable (N/A).
1Measured in cage/inoculation experiments; 2Measured in full colonies;
As effective as fumagillin according to authors;
Less effective than fumagillin according to authors;
Four in-house synthetic fumagillin analogs were tested;
Tested only in Apis cerana;
Tested only in Apis florea;
Van den Heever et al. (46) found no effect;
Bee mortality varied between treatments and compound concentrations; +β-phellandrene, eucalyptol, and α-terpineol.